SUSMED Co., Ltd. announced a private placement for gross proceeds of ¥720,000,000 on June 4, 2018. The transaction included participation from new investors Tokyo Century Corporation (TSE:8439), M3, Inc. (TSE:2413), SBI Investment Co., Ltd., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited, and existing investor Beyond Next Ventures Inc. The company issued shares through a third party allocation method.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
542 JPY | -3.56% | -1.28% | -59.40% |
2023 | SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index | CI |
2022 | Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,624 JPY | -3.91% | -1.40% | 7.07B | ||
1,504 JPY | -0.73% | -3.96% | 4.72B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.40% | 58.16M | |
-12.70% | 193B | |
+2.65% | 169B | |
+2.20% | 154B | |
+5.96% | 101B | |
+11.22% | 80.9B | |
+25.63% | 77.58B | |
-7.65% | 70.81B | |
-21.03% | 52.48B | |
-10.22% | 42.67B |
- Stock Market
- Equities
- 4263 Stock
- News SUSMED,Inc.
- SUSMED Co., Ltd. announced that it has received ¥720 million in funding from Tokyo Century Corporation, M3, Inc., SBI Investment Co., Ltd., Beyond Next Ventures Inc., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited